Harrison "Hap" Farber is Professor of Medicine and Director of the Pulmonary Hypertension Center at

Boston University Boston University (BU) is a private research university in Boston, Massachusetts. The university is nonsectarian, but has a historical affiliation with the United Methodist Church. It was founded in 1839 by Methodists with its original campu ...

. He attended undergraduate at

Duke University Duke University is a private research university in Durham, North Carolina. Founded by Methodists and Quakers in the present-day city of Trinity in 1838, the school moved to Durham in 1892. In 1924, tobacco and electric power industrialist James ...

before moving to

Belgium Belgium, ; french: Belgique ; german: Belgien officially the Kingdom of Belgium, is a country in Northwestern Europe. The country is bordered by the Netherlands to the north, Germany to the east, Luxembourg to the southeast, France to th ...

and became a member of the Belgium cycling team. He then went on to attend medical school at

George Washington University , mottoeng = "God is Our Trust" , established = , type = Private federally chartered research university , academic_affiliations = , endowment = $2.8 billion (2022) , preside ...

and entered into residency at the Medical College of Virginia. He completed a fellowship in pulmonary and critical care medicine at Boston University and Boston City Hospital Program. Dr. Farber completed an additional research year at Beth Israel Deaconess Hospital in basic science. Dr. Farber was a Professor in the Department of Medicine and attended in the Medical Intensive Care Unit and on the Pulmonary Consultation Service at Boston Medical Center. He also oversaw the care of all patients with Pulmonary Hypertension at Boston Medical Center. He is currently the director of the pulmonary embolism emergency response team (PERT) at Tufts New England Medical Center. Dr. Farber's research focuses on the response of the pulmonary vasculature (''the disposition or arrangement of blood vessels in an organ or part'') to injury and

endothelial The endothelium is a single layer of squamous endothelial cells that line the interior surface of blood vessels and lymphatic vessels. The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel ...

cell biology. He has extensive government and private funding. He is a member of several research groups both within the Pulmonary Center and in other divisions within the Department of Medicine: the Pulmonary Vascular Biology Group (Pulmonary Center); the Center for Excellence in Sickle Cell Disease (Hematology), the Scleroderma Vascular Disease Group (

Rheumatology Rheumatology (Greek ''ῥεῦμα'', ''rheûma'', flowing current) is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones, muscles, joints, and internal organs. Rheumatolog ...

) and Pulmonary Vascular/Left Ventricular Study Group (

Cardiology Cardiology () is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart d ...

). Dr. Farber's laboratory is investigating the response of the pulmonary vasculature in different etiologies of pulmonary hypertension using genomic and proteomic approaches to identify unique molecules as potential targets for new therapies for pulmonary

hypertension Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure usually does not cause symptoms. Long-term high bl ...

associated.

Selected publications

*Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman, JS, Farber HW. Sarcoidosis associated pulmonary hypertension: Outcome with long-term epoprostenol treatment (submitted). *Klings ES, Odhiambo, A, Li, G, Adewoye AH, Ieong, MH, Leopold JA, Steinberg MH, Farber HW. Reactive oxygen species-dependent induction of VCAM-1 expression in cultured pulmonary artery endothelial cells: Effects of sickle cell plasma (submitted) *Wilson KW, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: A severe iatrogenic illness in intensive care unit patients receiving intravenous benzodiazepines. Chest 2005; 128: 1674–1681. *Farber HW, Loscalzo J. Pulmonary Hypertension (Mechanisms of Disease). N Engl J Med 2004; 351:1655-1665

References

{{DEFAULTSORT:Farber, Harrison Boston University alumni Boston University faculty George Washington University School of Medicine & Health Sciences alumni Harvard Medical School people Living people Duke University alumni American scientists Year of birth missing (living people)